Study group n = 150 | No CAD | CAD 50%-70% | CAD > 70% | p value |
---|---|---|---|---|
Patients n (%*) | 48 | 41 | 61 | - |
Age, mean(± 1 SD), y | 64 (10) | 69 (9) | 70 (9) | ns |
Men, n (%) | 26 (54) | 24 (59) | 40 (65) | ns |
Risk factors ≥2, n (%) | 37 (77) | 34 (85) | 51 (84) | ns |
Hypertension, n (%) | 32 (67) | 30 (73) | 42 (69) | ns |
Diabetes Mellitus n (%) | 6 (13) | 12 (29) | 19 (31) | ns |
Prior myocardial infarction or PCI n (%) | 11 (23) | 13 (32) | 23 (38) | ns |
Presence of baseline WM abnormalities, n % | 10 (21) | 14 (34) | 24 (39) | ns |
Baseline LVEF, % | 57 ± 8 | 54 ± 9 | 52 ± 10 | ns |
Abnormal WM, n (%) | 8 (17) | 15 (37) | 52 (85) | p < 0.001 |
Abnormal myocardial perfusion n (%) | 15 (31) | 40 (98) | 58 (95) | ns |
Peak RPP mean(± 1 SD) | 15124 (3140) | 15416(3684) | 14615(2705) | ns |